U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06984926) titled 'A Study to Test How Well Multiple Doses of BI 3810477 Are Tolerated by Healthy Adults' on May 15.
Brief Summary: The main objectives of this trial are to investigate safety, tolerability, and pharmacokinetics of BI 3810477 in healthy male and female trial participants when given as multiple rising doses.
Study Start Date: June 05
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: BI 3810477
BI 3810477
DRUG: Placebo
Placebo for BI 3810477
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Boehringer Ingelheim
Published by HT Digital Content Services with permission from Health Daily Digest....